Ligand · 0BQ
0BQ · 5-(1H-benzimidazol-2-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one
0BQ, 5-(1H-benzimidazol-2-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one (C9 H7 N5 O, 201.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds…
- Component
- 0BQ
- Formula
- C9 H7 N5 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
0BQ in 2 structures; the first of them:
- 7N5O · Fragment-Based Discovery of a Novel Bruton's Tyrosine Kinase Inhibitor · 0BQ A703 · binds LEU408, VAL416, ALA428, LYS430, VAL458, THR474, GLU475, TYR476 and 5 more
- 7N5O · Fragment-based discovery of a novel BRUTON'S tyrosine kinase inhibitor · 0BQ A703 · binds LEU408, ALA428, LYS430, THR474, GLU475, TYR476, MET477, ALA478 and 2 more
Residues it binds most
ALA 2, LEU 2, GLU 2, GLY 2, LYS 2, MET 2, THR 2, TYR 2, VAL 1, ASN 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.